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Abstract Objective: To describe
the time course of high frequency
oscillatory ventilation (HFOV) in
respiratory syncytial virus (RSV)
bronchiolitis. Design: Retrospective
charts review. Setting: A tertiary
paediatric intensive care unit.
Patients and participants: Infants
with respiratory failure due to RSV
infection. Intervention: HFOV.
Measurements and results: Pattern
of lung disease, ventilatory settings,
blood gases, infant’s vital parameters,
sedation and analgesia during the
periods of conventional mechanical
ventilation (CMV, 6 infants), after
initiation of HFOV (HFOVi, 9
infants), in the middle of its course
(HFOVm), at the end (HFOVe) and
after extubation (Post-Extub) were
compared. All infants showed a pre-
dominant overexpanded lung pattern.
Mean airway pressure was raised
from a mean (SD) 12.5 (2.0) during
CMV to 18.9 (2.7) cmH2O during
HFOVi (P \ 0.05), then decreased to
11.1(1.3) at HFOVe (P \ 0.05).
Mean FiO2 was reduced from 0.68
(0.18) (CMV) to 0.59 (0.14) (HFOVi)
then to 0.29 (0.06) (P \ 0.05) at
HFOVe and mean peak to peak
pressure from 44.9 (12.4) cmH2O
(HFOVi) to 21.1 (7.7) P \ 0.05
(HFOVe) while mean (SD) PaCO2
showed a trend to decrease from 72
(22) (CMV) to 47 (8) mmHg
(HFVOe) and mean infants respira-
tory rate a trend to increase from 20
(11) (HFOVi) to 34 (14) (HFOVe)
breaths/min. With usual doses of
sedatives and opiates, no infant was
paralysed and all were extubated to
CPAP or supplemental oxygen after a
mean of 120 h. Conclusion: RSV
induced respiratory failure with
hypercapnia can be managed with
HFOV using high mean airway pres-
sure and large pressure swings while
preserving spontaneous breathing.
Keywords Respiratory syncytial
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Introduction
Despite the use of non invasive respiratory support such
as CPAP [1, 2], helium–oxygen mixture [3], alone or in
combination [4], the proportion of infants with RSV
infection requiring conventional mechanical ventilation
(CMV) is still reported to vary around 25% in those
requiring intensive care admission [1, 5]. Adequate CMV
in obstructive lung disease represents a challenge. High
tidal volumes and minute ventilation are required imply-
ing high peak pressures, risk of air leaks, and an almost
universal use of muscular paralysis [6]. The use of high
frequency oscillatory ventilation (HFOV) has been
described in a few cases [7–10] as a rescue intervention to
improve severe hypoxemic respiratory failure while CO2
elimination was yet achieved. In this report, we aim to
Intensive Care Med (2008) 34:1698–1702
DOI 10.1007/s00134-008-1151-3 BRIEF REPORT
describe the time course of HFOV in RSV proven
infection with predominantly hypercapnic respiratory
failure as an effective alternative to conventional
mechanical respiratory support.
Methods
Charts of all infants with confirmed RSV bronchiolitis
treated with high frequency oscillatory ventilation
between 01.01.1998 and 01.01.2007 were reviewed.
Those with a known underlying condition susceptible to
modify the nature or the course of the lung disease such as
broncho-pulmonary dysplasia, pulmonary congenital
malformation or non operated congenital heart disease
were excluded. The obstructive pattern of the lung disease
for 6 infants initially on CMV, was determined according
to the relation between mean airway pressure and the
alveolo–arterial oxygen pressure difference (AaDO2)
described by Tasker et al. [11] and lung expansion was
assessed for each infant by counting the total number of
visible ribs (on both hemithoraces) above the diaphragm
on the initial chest X-ray as described by Greenough et al.
[12], 16 ribs being the cut-off value for the presence of
lung overexpansion.
During the course of mechanical ventilation, no
pharmacological treatment such as corticosteroids, b2 or
a-1adrenegic agonists were administered. Bacterial co-
infection was suspected on clinical deterioration and
antibiotics given if gram staining of tracheal secretions,
blood leucocytes count, differential and serum CRP were
considered abnormal.
CMV was delivered with a Babylog 8000 (Dra¨ger,
Lubeck, Germany) in a pressure controlled mode and
HFOV through an electromagnetically driven membrane
oscillator (3100 A Sensor Medics Critical Care, Yorba
Linda, CA, USA). Frequency was started between 8–
12 Hz with an I:E ratio of 0.33 and mean airway (meanaw)
pressure 2 cmH2O above the last value set during con-
ventional ventilation. It was raised by steps of 2 cmH2O
aiming at an arterial saturation above 88% until a
reduction in FiO2 could be initiated. Additional recruit-
ment manoeuvres were not attempted. Peak to peak
pressure amplitude was started at a value where chest
movements could be visually detected and stepwise
increased to reach and maintain the pH above 7.25 irre-
spective of the PaCO2. Infants received midazolam or
chloral hydrate for sedation and morphine sulphate for
analgesia. Muscular paralysis was avoided as long as not
specifically required.
Ventilatory settings (FiO2, meanaw pressure, peak to
peak amplitude, ventilatory frequency, I:E ratio), blood
gases and vital signs (infants respiratory rate, mean arte-
rial blood pressure and heart rate) were extracted during
conventional mechanical ventilation (period CMV), a
mean of 3 h (±40 min) after the switch to HFOV (period
HFOVi), mid course (period HFOVm), just prior stopping
HFOV (period HFOVe) and after extubation either on
CPAP and/or supplemental oxygen therapy (Post-Extub).
Statistics
Kruskall–Wallis non parametric analysis of variance was
performed to compare periods of respiratory support for
ventilatory variables, gas exchanges and vital signs using
a PRISM 4.0 package (GraphPad software). P \ 0.05 was
considered significant.
Results
A total of 13 infants with RSV proven lung infection were
treated with HFOV during the study period. Four cases
were excluded from analysis (two with congenital pul-
monary malformation, two with unrepaired congenital
cardiac disease). Three infants, transferred after intuba-
tion from another unit or hospital were treated with
HFOV as first intention. Six infants, intubated in our ICU,
were put on HFOV after a median (25–75%) period of
CMV of 3.5 (1–32.5) h. The relevant demographic data,
initial lung pattern and clinical course are described in
Table 1. All infants attested of lung overexpansion on
chest X-ray [12] while none fulfilled the criteria for an
ARDS type of RSV infection [11]. Bacterial co-infection
was diagnosed in five infants (56%). Before initiating
HFOV in the six cases under CMV, mean (SD) pH was
7.27 (0.15) units and PaCO2 72 (22) mmHg with a mean
peak inspiratory pressure of 26 (5) cmH2O and a PEEP of
6.5 (1) cmH2O. Changes in ventilatory settings, blood
gases, infants own respiratory rates, heart rates and mean
arterial pressures, doses of medication given during the
various periods of ventilation are summarized in Table 2.
No infant was paralyzed. Hemodynamically, two infants
were treated with dopamine. One infant had developed a
bilateral pneumothorax under CMV which resolved with
drainage and HFOV. Five infants were extubated to
CPAP, the other to simple supplemental oxygen and all
survived.
Discussion
Although mechanical ventilation at high frequencies is
usually considered to be contraindicated in lung disease
with increased airway resistance, the successful use of
1699
rescue HFOV in a few infants with bronchiolitis to correct
severe hypoxemia [7–9] or in a case of status asthmaticus
[14] has yet been published. Our report documents that
HFOV can be used as an elective alternative to CMV to
support spontaneous respiration and improve gas
exchanges in infants with predominantly obstructive and
hypercapnic respiratory failure from small airway disease.
Indeed, despite bacterial co-infection in half of them,
either by scoring the chest X-ray [12] or plotting the
individual alveolo–arterial oxygen difference against
meanaw pressure [11], all infants showed a predominantly
overexpanded lung pattern [15].
In our view, the use of HFOV in bronchiolitis dem-
onstrates several advantages over CMV. It obviates the
need for infant ventilator synchrony and allows muscular
paralysis to be avoided. PaCO2 can be controlled by
adjusting peak to peak pressure while the infant continues
actively to contribute to expiration under usual sedation.
We consistently observed that the infant’s respiratory rate
slowly increased as pressure amplitudes were decreased
(see Fig. 1). A bilateral pneumothorax observed under
CMV resolved during HFOV and no new air-leak
occurred but the number of infants is too small to draw
conclusions. Hemodynamically, a few infants did require
adrenergic support but renal function was well preserved
as suggested by the physiological metabolic compensa-
tion of the respiratory acidosis that occurred over time.
The mean duration of HFOV was either similar [11, 16]
or slightly shorter to that reported in infants with
obstructive bronchiolitis using CMV [6, 15] and all
patients could be extubated directly to CPAP or supple-
mental Oxygen.
The major limitation of this report is its retrospective
and descriptive nature. HFOV settings were set on
pragmatic grounds because the actual knowledge on
mechanisms governing pressure and flow transmission
when peripheral airway resistance is high, is scarce
[17].
Table 1 Demographic and initial clinical data of the nine infants, six with prior CMV
No. Age at entry
(days)
Weight
(g)
Aa–DO2
(mmHg)
Mean airway
pressure
(cmH2O)
Number of ribs
visiblea
HFOV
length
(h)
Bacterial co-infection
1 28 4,000 – – 19 94
2 36 3,600 – – 16 120
3 80 2,900 326 14 19 135 K. Pneumoniae
4 112 5,800 125 14 18 192
5 35 2,300 289 14 22 104
6 32 3,055 342 12 20 60 H. Influenzae
7 49 3,700 376 10 17 139 S. Pneumoniae
8 114 2,900 236 11 17 147 S. Pneumoniae
9 19 4,000 – – 20 93 H. Influenzae
Mean (SD) 56 (34) 3,585 (950) 282 (25) 12.5 (2) 18.7 (1.8) 120 (38)
a Number of visible ribs above the diaphragms on both lung fields: significant lung overexpansion is recognized above 16 ribs [12]
Table 2 Mean (SD) of ventilatory settings, blood gases, infants respiratory rate and dosage of sedatives and analgesics through the
different periods of respiratory support
CMV (n = 6) HFOi (n = 9) HFOm (n = 9) HFOe (n = 9) Post-Extub (n = 9)
Mean airway pressure (cmH2O) 12.5 (2) 18.9* (2.7) 14.5 (3.3) 11.1** (1.3)
Peak to peak pressure (cmH2O) 44.9 (12.4) 39.3 (11) 21.1** (7.7)
HFOV Frequency (Hz) 11.1 (1.9) 10.9 (1.5) 10.4 (2.0)
FiO2 (%) 68 (18) 59 (14) 36 (8) 29** (6) 26 (5)
pH 7.27 (0.15) 7.33 (0.08) 7.37 (0.04) 7.42** (0.03) 7.40 (0.03)
PaCO2 (mmHg) 72 (22) 56 (10) 54 (9) 47 (8) 51 (7)
Base excess 3.5 (4) 3.2 (5) 5.5 (3.3) 7.0 (2.6) 6.1 (2.4)
Respiratory rate (breaths/min) 61 (20) 20* (11) 34 (19) 34 (14) 41 (11)
Heart rate (beats/min) 168 (19) 156 (16) 137 (16) 140 (26) 136 (20)
Mean arterial pressure (mmHg) 49 (19) 52 (11) 52 (9) 49 (7) 62 (10)
Mean midazolam (c/kg/h) (SD) 110 (66) 113 (64) 106 (69)
Mean morphine (c/kg/h) (SD) 25 (18) 14 (12) 14 (12) 14 (12)
CMV Conventional mechanical ventilation, HFOVi initial period of high frequency oscillatory ventilation, HFOVm middle period during
high frequency oscillatory ventilation, HFOVe end period of high frequency oscillatory ventilation. *P \ 0.05 CMV vs HFOVi.
**P \ 0.05 HFOVi vs HFOVe
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In this view, three settings deserve comments: the
large peak to peak pressure, the low ventilatory frequency
and the high meanaw pressure compared to HFOV in
idiopathic respiratory distress syndrome [18]. Such set-
tings seem at first poorly adapted to the ventilation of
obstructive lung disease. However, with HFOV, the
transmission of pressures and volumes delivered by the
ventilator is exquisitely sensitive to the mechanical
properties of the respiratory system and the endotracheal
tube [19]. Thus, the requirement of high peak to peak
pressure can be explained by the dampening that occur
through the small endotracheal tube and down the highly
resistive airway of these infants, reducing pressure swings
and effective tidal volume [19, 20]. A low frequency can
thus be advocated to maintain an adequate tidal volume
once high amplitude has been set.
The high meanaw pressure required at the airway
opening is a hallmark of all cases reported with HFOV
in small airway disease [9, 10, 13] and represents the
most intriguing setting. It is partly attributed to the
pressure drop occurring through the flow dependant
resistance of the endotracheal tube which is accentuated
when using an I:E of 0.33 generating higher inspiratory
than expiratory flows [19]. More importantly, this high
meanaw pressure is considered necessary to generate a
sufficient pressure to open and stent the collapsed small
airway, allowing pressure swings to be transmitted
peripherally and alveolar ventilation to resume in
obstructed lung units. In this concept termed the ‘‘open
airway’’ concept, meanaw pressure becomes a major
determinant of CO2 elimination [9, 10, 13, 14]. The
optimal pressure required to open the peripheral airway
without causing alveolar overdistention and adverse
cardiovascular effects must lie in a narrow range. It still
requires an experimental set- up to be approximated
scientifically [20].
In conclusion, HFOV seems a valuable tool to support
spontaneous respiration and gas exchange in infants with
respiratory failure due to the common obstructive lung
pattern of RSV infection. Determination of optimal ven-
tilatory settings remains a difficult clinical task due to the
complexity of the interaction between meanaw pressure,
frequency, pressure amplitude and mechanical charac-
teristics of the respiratory system.
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